For more information about strategic partnerships or other business development opportunities, please complete the form below.
Intrance Medical Systems is currently seeking strategic partnerships with leading biopharmaceutical companies for the company’s lead asset, known as Lecigon® in Europe, including:
Out-licensing partnerships for Japan, Taiwan, Canada, Central and South America.
Commercialization partner in the U.S.
Through partnerships and collaboration, we can leverage our novel approach aimed at bringing innovation to the Parkinson’s disease community and beyond to potentially address other debilitating neurodegenerative diseases and central nervous system (CNS) disorders.